FOLD earnings: a negative outcome, -5.0%

On May 10, 2023, Amicus Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.0% in the window around the event. It had already run +9.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.